JUMPCAN(SH:600566)2017-10-16 16:00Financial Performance - Operating income rose by 20.17% to CNY 4,213,619,124.43 for the year-to-date period[7] - Net profit attributable to shareholders increased by 34.18% to CNY 907,316,557.12 year-to-date[7] - Basic and diluted earnings per share increased by 31.57% to CNY 1.121[7] - Total operating revenue for the first nine months reached CNY 4,213,619,124.43, a 20.1% increase from CNY 3,506,475,980.26 in the same period last year[26] - Net profit attributable to shareholders for the third quarter was CNY 325,505,366.88, compared to CNY 235,718,169.91 in the previous year, representing an increase of approximately 38.1%[28] - Operating profit for the first nine months was CNY 985,879,698.91, up from CNY 756,675,102.23, indicating a growth of about 30.2%[28] - Total profit for the first nine months was CNY 1,060,108,174.15, an increase from CNY 787,934,644.89, marking a growth of around 34.5%[28] Cash Flow - Net cash flow from operating activities surged by 49.03% to CNY 992,431,894.34 year-to-date[7] - Operating cash flow net amount increased by 49.03% to ¥992,431,894, due to expanded sales and improved cash collection[13] - The net cash flow from operating activities for the third quarter was CNY 992,431,894.34, an increase from CNY 665,926,730.88 in the same period last year, representing a growth of approximately 49%[36] - The total cash inflow from operating activities for the first nine months was CNY 166,585,469.88, a decrease from CNY 410,699,360.33 in the previous year[38] - The net cash flow from operating activities for the first nine months was CNY 20,853,196.02, a significant decline from CNY 395,776,329.55 in the previous year[38] Assets and Liabilities - Total assets increased by 12.17% to CNY 5,594,710,856.10 compared to the end of the previous year[7] - The company reported a total liability of CNY 1,670,426,909.98, up from CNY 1,300,103,518.97 year-on-year, indicating a 28.5% increase[21] - Owner's equity totaled CNY 3,924,283,946.12, compared to CNY 3,657,337,648.36 at the beginning of the year, reflecting a growth of 7.3%[21] - Current liabilities increased to CNY 575,342,680.09 from CNY 412,886,719.46, marking a 39.4% increase[25] - The company’s non-current assets remained stable at CNY 7,249,670,644.20, slightly up from CNY 7,169,670,644.20[24] Investments and Expenditures - Investment cash flow net amount decreased by 81.65% to -¥619,068,273, primarily due to increased fixed asset investments and the acquisition of Shanghai Zhenxin Enterprise Management Consulting Co., Ltd.[13] - Cash outflow for purchasing fixed assets and other long-term assets was CNY 80,000,000.00, compared to CNY 667,331,405.20 in the previous year, indicating a significant reduction in capital expenditures[39] Shareholder Information - The total number of shareholders reached 9,936 by the end of the reporting period[10] - The company completed the acquisition of the remaining 20% minority interest in Dongke Pharmaceutical, resulting in a 100% decrease in minority interests[13] Regulatory and Strategic Moves - The company received approval from the China Securities Regulatory Commission for the public issuance of convertible bonds, indicating a strategic move to raise capital[15]